UNION therapeutics further strengthens management team with medical and business development profiles
· Dr. Per Cantor, MD, DMSci, appointed as new Chief Medical Officer · Mr. Eckhard Niemeier appointed as Chief Business Officer · Mr. Mads Jellingsø promoted to Chief Commercial Officer Hellerup, Denmark, 31 May 2021 – UNION therapeutics A/S, a privately held, multi-asset, clinical stage, pharmaceutical company focusing on infectious and inflammatory diseases, announces onboarding of Dr. Per Cantor, MD, DMSci, as the Chief Medical Officer, effective as of 1 April 2021. Also, as of 1 June 2021, Mr. Eckhard Niemeier, MSc Biotechnology, will join UNION as Chief Business Officer. At the